EA
BIND

Emerald Advisers’s BIND THERAPEUTICS INC BIND Stock Holding History

Emerald Advisers’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,010
Closed -$119K – 454
2014
Q2 		$119K Sell
9,010
-33,113
-79% -$324K 0.01% 384
2014
Q1 		$504K Sell
42,123
-377,629
-90% -$4.93M 0.03% 283
2013
Q4 		$6.33M Buy
419,752
+209,612
+100% +$2.67M 0.34% 103
2013
Q3 		$2.97M Buy
+210,140
New +$3.03M 0.17% 157

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Advisers's BIND Position: Q3 2014 in Review

Emerald Advisers sold out of BIND THERAPEUTICS INC (BIND) in Q3 2014, closing a stake of 9,010 shares — an estimated $119K sold.

Emerald Advisers first reported a position in BIND in Q3 2013 and held it in 4 quarters. The position peaked at $6.33M in Q4 2013. 40 funds tracked by Wall St. Rank hold BIND as of Q3 2014.

  • Emerald Advisers reported no remaining BIND THERAPEUTICS INC position as of Q3 2014 after selling out during the quarter.
  • Emerald Advisers sold 9,010 BIND THERAPEUTICS INC shares in Q3 2014, an estimated $119K.
  • Emerald Advisers first reported a position in BIND THERAPEUTICS INC in Q3 2013 and held it in 4 quarters.
  • Emerald Advisers's BIND THERAPEUTICS INC position peaked at $6.33M in Q4 2013.
  • 40 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2014.

Based on Emerald Advisers's 13F filing for Q3 2014, filed 28 Oct 2014.